Revenue segments as reported by the company.

Premiums

Product revenue

Administrative fees and other revenue

Net investment income

Net gains on financial instruments

Gain on sale of business

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit expense

Selling, general and administrative

Interest expense

Amortization of other intangible assets

Loss on extinguishment of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Elevance Health Inc

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The firm supports consumers, families, and communities across the entire care journey, connecting them to the care, support, and resources they need to lead healthier lives. It offers health plans and clinical, behavioral, pharmacy, and complex-care solutions which promote whole health. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Elevance Health reports robust Q4 earnings, eyes margin optimization

Elevance Health's strong Q4 2022 performance, strategic acquisitions, and focus on margin optimization position the company for continued growth. With a clear outlook for 2023, emphasizing membership expansion and margin recovery, the company is poised for success. Challenges in optimizing margins and managing cost structures are balanced by growth opportunities and strategic initiatives.

Elevance Health reports robust Q1 growth and innovation in healthcare

Elevance Health Inc demonstrated strong financial performance and growth in Q1 2023, driven by increased membership and solid operating results.
The company's focus on advocacy, innovation, and sustainability, along with strategic investments in healthcare capabilities, positions it for continued success.
While facing challenges in cost management and strategic partnerships, Elevance Health is well-positioned to capitalize on opportunities in specialty care and value-based models.
Overall, Elevance Health's commitment to whole health, innovation, and value-based care sets a positive trajectory for future growth and industry leadership.

Elevance Health Inc posts robust Q2 earnings, eyes value-based care

Elevance Health Inc reported strong Q2 earnings, raised adjusted EPS outlook to over $32.85 for the year, and emphasized a focus on value-based care and digital solutions. While facing margin pressure in Carelon, the company remains confident in its strategy execution and performance for 2023 and beyond.

Elevance Health excels in Q3, eyes growth through strategic actions

Elevance Health's Q3 performance was strong, with a focus on operational efficiency and strategic investments. Challenges in Medicare ratings were addressed through proactive measures, while opportunities lie in growth acceleration and strategic partnerships. The company remains on track to achieve its long-term growth targets.

Elevance Health Inc surpasses earnings expectations, eyes growth opportunities

Elevance Health Inc's strong financial performance in Q4 2023 and full-year results, coupled with strategic initiatives in expanding capabilities and enhancing operational efficiency, position the company for continued success. Challenges in commercial repricing and Medicaid dynamics are being addressed, while opportunities in Medicare Advantage and strategic investments offer avenues for growth.

Elevance Health posts robust Q1 earnings, eyes strategic growth

Elevance Health demonstrated strong financial performance in Q1, with revenue growth and margin expansion in key segments.
While facing challenges like potential Medicare rate cuts, the company is leveraging partnerships and acquisitions for growth.
Opportunities lie in expanding service offerings, geographic footprint, and optimizing Medicaid margins for long-term sustainability.

Elevance Health Inc reports robust earnings growth and strategic wins

Elevance Health's Q2 performance reflects strong earnings growth and reaffirmed guidance, driven by solid segment performance and new business wins.
The company's strengths lie in its high Medicare rating, robust revenue growth in services, and strategic focus on value creation.
Challenges include sustaining growth momentum, managing funding cuts, and effectively integrating recent acquisitions for long-term success.
Opportunities exist in accelerating capabilities, expanding market share, optimizing operations, and leveraging workplace recognition for talent attraction and innovation.

Elevance Health faces Medicaid challenges, sees growth in AI investments

Elevance Health's Q3 earnings were impacted by elevated medical costs in Medicaid, leading to a reduction in full-year outlook. Despite challenges in the Medicaid business, the company's Medicare Advantage and Commercial businesses are performing well. Investments in AI and expansion of Carelon Services present growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health (ELV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Elevance Health, Inc. (ELV) Hit a 52 Week High, Can the Run Continue?

This insurance stock hit buy a point on the chart and is in the buy zone. The stock has taken off since its positive Q3 earnings report.

Insurance Stock Hits New High To Key Level

Humana

McKesson

All three stocks are up double-digit percentages in 2022, leaving the S&P 500's performance in the dust. With the stocks carrying favorable near-term earnings outlooks, the run could easily continue.

3 Top-Ranked Medical Stocks Lapping the S&P 500

INDIANAPOLIS--(BUSINESS WIRE)--The Board of Directors of Elevance Health (NYSE: ELV) announced that Deanna Strable will be joining the Board.

Elevance Health Board Welcomes Deanna Strable as New Director

Elevance Health (ELV) could produce exceptional returns because of its solid growth attributes.

Here is Why Growth Investors Should Buy Elevance Health (ELV) Now

Elevance Health's third-quarter earnings beat is a sign of the times as the company resumes its upward trajectory. Membership premium growth and pharmacy income contribute to a phenomenal revenue mix.

Elevance Health: Assessing Prospects After Q3 Earnings Beat

Elevance Health (ELV) is witnessing rapid growth in medical enrollment and expects to keep doing so.

Elevance Health (ELV) Beats on Q3 Earnings, Ups '22 EPS View

Elevance Health Inc. (NYSE:ELV ) Q3 2022 Earnings Conference Call October 19, 2022 8:30 AM ET Company Participants Steve Tanal – Vice President-Investor Relations Gail Boudreaux – President and Chief Executive Officer John Gallina – Chief Financial Officer Morgan Kendrick – President-Commercial and Specialty Business Division Peter Haytaian – President-Carelon Felicia Norwood – President-Government Business Division Conference Call Participants A.J. Rice – Credit Suisse Lance Wilkes – Bernstein Scott Fidel – Stephens Nathan Rich – Goldman Sachs Steven Valiquette – Barclays Rob Cottrell – Cleveland Research Lisa Gill – JPMorgan Kevin Fischbeck – Bank of America Gary Taylor – Cowen Whit Mayo – SVB Securities Dave Windley – Jefferies Operator Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Third Quarter Earnings Conference Call.

Elevance Health Inc. (ELV) Q3 2022 Earnings Call Transcript

INDIANAPOLIS--(BUSINESS WIRE)---- $ELV #earnings--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2022 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share.

Elevance Health Reports Third Quarter 2022 Results, Raises Full Year Outlook

Apollo Global Management

Fidelity National Financial

JPMorgan Chase & Co

Lithia Motors

OneMain Hld

Primerica

Raymond James

United Rentals

Valvoline

Born in New York in 1947, Glenn Greenberg is the son of baseball player Hank Greenberg.

These Are Glenn Greenberg's Top 10 Holdings

Elevance Health's (ELV) third-quarter results are likely to reflect improved premiums and net investment income.

Elevance Health (ELV) to Post Q3 Earnings: A Beat in the Cards?

Over the last year, the S&P 500 Index has lost nearly 18%. Every sector, save energy, is lower over that period of time.

Elevance Health: Choose Predictably

Elevance Health (ELV) devises suitable Medicare Advantage plans containing supplemental benefits, which consumers can avail in the 2023 Annual Enrollment Period.

Elevance Health's (ELV) Low-Cost MA Plans to Widen U.S. Base

INDIANAPOLIS--(BUSINESS WIRE)---- $Anthem #Anthem--Elevance Health's affiliated health plans will offer $0 premium Medicare Advantage plans with enhanced supplemental benefits.

Elevance Health announces its affiliates will offer affordable Medicare Advantage plans with comprehensive benefits and a simplified customer experience during Annual Enrollment Period

INDIANAPOLIS--(BUSINESS WIRE)---- $Anthem #Anthem--Elevance Health's 2023 affiliated Medicare Advantage plans have earned an overall quality rating of 4 out of 5 Stars from CMS.

Elevance Health's Affiliated 2023 Medicare Advantage Health Plans Earn High Quality Scores from CMS

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2022 financial results on October 19, 2022, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 (Domestic) 800-813-5525 (Domestic Replay) 312-470-0178 (International) 203-369-3346 (Interna

Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter Results on October 19, 2022

INDIANAPOLIS--(BUSINESS WIRE)-- #HurricaneIan--As part of its commitment to communities across the U.S., Elevance Health and its philanthropic arm Elevance Health Foundation provides support relief efforts to assist those affected by Hurricane Ian and other natural disasters. “We are deeply saddened by the loss of life and the immense destruction that Hurricane Ian has left behind. And that's why, as a lifetime, trusted health partner, we are announcing additional support in Florida so that affected communitie

Elevance Health Responds to Florida Communities Affected by Hurricane Ian

Bank of America

Copart

Dover

NextEra Energy

Nucor

PPG Industries

Teradyne

Thermo Fisher Scientific

UnitedHealth Group

October is infamous for "jinxing" investors with massive drops — the last thing anyone wants following September's fall. The post 10 Stocks Completely Avoid The Looming October 'Jinx' appeared first on Investor's Business Daily.

10 Stocks Completely Avoid The Looming October 'Jinx'

AstraZeneca

Medtronic

Sanofi

Inflation is easing, says a top thinker for BlackRock, the world's largest asset manager. But it's not falling to what Americans have grown used to.

BlackRock's DeSpirito: Brace For Stubborn Inflation

Apple

Cigna

Alphabet

HCA Healthcare

Microsoft

Micron Technology

Taiwan Semiconductor Manufacturing

Lewis Sanders is the founder, CEO, and Co-CIO of Sanders Capital. Sanders founded Sanders Capital in 2009, and prior to that, he worked for AllianceBernstein in varying roles, including Chairman, CEO, CIO and more.

These Are the Top 10 Holdings of Lewis Sanders

Centene

Managed health care stocks fall within the Medical-Managed Care group, which ranks a high No. 15 out of the 197 industries IBD tracks.

Managed Medical Care Stocks Group Moving Up The Ranks

INDIANAPOLIS--(BUSINESS WIRE)--The Elevance Health Foundation, the philanthropic arm of Elevance Health Inc., today announces the commitment of $22.8 million in grants for programs that leverage food as medicine. With an overall goal of helping individuals and families reach optimal health through good nutrition, each of these grants will focus on the following: using food interventions to help prevent or manage chronic conditions, improving access to and distributing food while providing long-

Elevance Health Foundation Commits More Than $22 Million to Food as Medicine Programs

BJ`s Wholesale Club Holdings Inc

Mercer International

MGIC Investment

RCM Technologies

As brokers have a deeper understanding of the stocks, one must follow rating upgrades. We pick BJ's Wholesale Club (BJ), Elevance Health (ELV), MGIC Investment (MTG), Mercer International (MERC) and RCM Technologies (RCMT) as these witness rating upgrades.

Buy These 5 Stocks With Upgraded Broker Ratings Right Away

Progressive

Glenn Greenberg (Trades, Portfolio)'s Brave Warrior Advisors recently disclosed its 13F portfolio updates for the second quarter of 2022, which ended on June 30.

Glenn Greenberg Is Going All In on This Subprime Lending Giant

CVS Health

Raytheon Technologies

TE Connectivity PLC

The second quarter of 2022 saw the U.S. Federal Reserve continue hiking interest rates as inflation remained sky-high. Unless companies can raise their profits more than 9% year over year to surpass inflation, they are effectively seeing their profits decrease on an inflation-adjusted basis, which is not exactly a recipe for a bull market.

News for Elevance Health Inc Stock (ELV)